Cohance Lifesciences Limited (COHANCE) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE03QK01018
Key metrics
- Market Cap
- ₹17,213 Cr
- P/E Ratio
- 164.2
- EPS
- 2.74
- Book Value
- 105.44
- P/B Ratio
- 4.3
- ROE
- 4.44%
- ROCE
- 5.58%
- Debt / Equity
- 0.1
- Net Margin
- 8.13%
- Revenue Growth
- -12.76%
- Profit Growth
- -63.22%
- Dividend Yield
- —
- 52W High
- ₹1,038.90
- 52W Low
- ₹266.70
- Market Cap Band
- mid cap
- Face Value
- 1
Ratios computed from the annual results period ending 2026-03-31.
About Cohance Lifesciences Limited
Cohance Lifesciences Limited engages in the contract research, development, and manufacturing of new chemical entity (NCE) based intermediates, active pharmaceutical ingredients (API), specialty chemicals, and formulated drugs in India, the United States, Europe, and internationally. The company offers small molecule APIs, advanced intermediates, and starting materials; antibody drug conjugates; high-purity oligonucleotide building blocks comprising phosphoramidites, nucleosides, pseudouridine, NTPs, CAP reagents, GalNAc conjugates, and fluorescent dyes; pellets and finished dosage forms (FDE); packaging and clinical trial support services; and specialty chemicals, including agrochemicals. It serves pharmaceutical, biotechnology, and chemical companies. The company was formerly known as Suven Pharmaceuticals Limited and changed its name to Cohance Lifesciences Limited in May 2025. The company was founded in 1989 and is headquartered in Hyderabad, India. Cohance Lifesciences Limited is a subsidiary of Berhyanda Limited.
- Headquarters
- Hyderabad, India
- Promoter Holding
- 63.96%
The full Cohance Lifesciences Limited analysis
Create a free account to open the complete COHANCE deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.